https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0045
Announcing a new article publication in
BIO Integration. According to World Health Organization (WHO) reports, parasitic infections substantially affect the world’s population and are responsible for more than 16 million annual deaths in developing countries. Trichomoniasis, giardiasis, cryptosporidiosis, and toxoplasmosis, the most common helminthic infections in humans, are treated with anthelmintics and antibiotics that achieve synergistic effects. The key anthelmintic drug Albendazole (ABZ) has drawbacks of low solubility. Anthelmintics fall under biopharmaceutics classification system (BCS) class II and are therefore administered through conventional approaches and novel nanomedicine techniques to enhance their biopharmaceutical properties and therapeutic efficacy. This review examined the literature on anthelmintics with appreciable benefits. Because the nanomedicine development of ABZ was contemporaneous with its repurposing as an anticancer agent, with or without nanoformulation, this review also addresses the repositioning of ABZ to treat diverse cancers including colon cancer, brain tumors, malignant melanoma, and breast cancer.
# # # # # #
BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.
As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience,
BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.
Please visit
www.bio-integration.org to learn more about the journal.
Editorial Board: https://bio-integration.org/editorial-board/
BIOI is available on the
ScienceOpen platform (
https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).
Submissions may be made using
ScholarOne (
https://mc04.manuscriptcentral.com/bioi).
There are no author submission or article processing fees.
Follow
BIOI on Twitter
@JournalBio;
Facebook (
https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and
LinkedIn (
https://www.linkedin.com/company/bio-integration-journal/).
ISSN 2712-0074
eISSN 2712-0082
Shachi Virlley, Mamta Arya and Arti Singh et al. Drug Delivery and Repurposing Approaches for Albendazole Formulations.
BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0045
# # # # # #